Jackson Grant Investment Advisers’s Quest Diagnostics DGX Stock Holding History

Jackson Grant Investment Advisers’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91K	Hold	9	–	–	﹤0.01%	395
2026 Q1	$1.76K	Hold	9	–	–	﹤0.01%	387
2025 Q4	$1.56K	Hold	9	–	–	﹤0.01%	387
2025 Q3	$1.72K	Hold	9	–	–	﹤0.01%	399
2025 Q2	$1.62K	Hold	9	–	–	﹤0.01%	373
2025 Q1	$1.52K	Hold	9	–	–	﹤0.01%	369
2024 Q4	$1.36K	Hold	9	–	–	﹤0.01%	387
2024 Q3	$1.4K	Hold	9	–	–	﹤0.01%	391
2024 Q2	$1.23K	Hold	9	–	–	﹤0.01%	390
2024 Q1	$1.2K	Hold	9	–	–	﹤0.01%	384
2023 Q4	$1.24K	Hold	9	–	–	﹤0.01%	377
2023 Q3	$1.1K	Hold	9	–	–	﹤0.01%	380
2023 Q2	$1.26K	Hold	9	–	–	﹤0.01%	397
2023 Q1	$1.27K	Buy	+9	New	+$1.29K	﹤0.01%	428

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Jackson Grant Investment Advisers's DGX Position: Q2 2026 in Review

Jackson Grant Investment Advisers held its Quest Diagnostics (DGX) position steady in Q2 2026 at 9 shares worth $1.91K. The position accounts for ﹤0.01% of the portfolio, ranked #395.

Jackson Grant Investment Advisers first reported a position in DGX in Q1 2023 and has held it in 14 quarters since. 444 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Jackson Grant Investment Advisers held 9 shares of Quest Diagnostics worth $1.91K as of Q2 2026.
Jackson Grant Investment Advisers left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of Jackson Grant Investment Advisers's portfolio in Q2 2026, its #395 holding.
Jackson Grant Investment Advisers first reported a position in Quest Diagnostics in Q1 2023 and has held it in 14 quarters since.
444 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.